Team Pump

Media Central (FLYY.C) announces end of journalism for alternative weeklies Georgia Straight and NOW

When a company shows up out of nowhere and announces they’re buying a newspaper, but that nothing will change if not for the better, that they have money and resources to compliment what’s already there, and that journalism will always be at the core of what they do, don’t buy it. It’s always a lie. In March, Media Central (FLYY.C) CEO Brian Kalish got in front of a camera to talk about how, ‘hey guys, we know the Georgia Straight has been around for 53 years, but we’re bringing it back to its heart.’

Read More »

European office supplies manufacturer takes Wayland Group (WAYL.C) weed grow for $12.3m

The Wayland Group (WAYL.C) announced Thursday Austria-based Ring Holding International AG will purchase their Maricann assets, which essentially make up their entire business, for the bargain price of $12.3 million as part of ongoing bankruptcy proceedings. The purchaser of the Maricann assets is a family office with a core focus on the manufacturing of lever arches used in ring binders. Yes, ring binders.

Read More »

Invictus MD Strategies (GENE.V) kicked off Venture Exchange after screwing up everything for three years straight

Invictus MD Strategies (GENE.V) announced tonight that, in accordance with its efforts to work through creditor protection proceedings, it has been kicked off the Venture Exchange. On the upside, if Invictus’ history of going back on news releases is anything to go by, we’ll receive another release inside ten days that the bankruptcy proceedings have been cancelled and they’ll continue on as usual. Because that’s how it’s always been for Invictus, which has the worst track record in Canada’s cannabis space for announcing things, only to un-announce them very shortly after.

Read More »

Wayland Group (WAYL.C) selling once hyped foreign assets for pennies on the dollar

As part of an ongoing process to deal with its bankruptcy, Wayland Group (WAYL.C) is dispensing with several foreign assets that were once touted as being amazing international opportunities, and it’s doing so at prices you can afford. The courts have granted approval for WAYL to get rid of its Colombian subsidiary, Colmed Pharmaceuticals, which was purchased in an all paper deal for 11 million shares a little over a year ago. Who’s buying it? It turns out, one of the companies that originally sold it to them, RG5 Investments.

Read More »

Equity Guru Podcasts